Go to Page # Page of 27

Marine-Derived Novel Moa Oncology Drugs

 PharmaMar
  18th-Apr-2017
Description: This document includes only summary information and is not intended to be comprehensive. This document includes "forward-looking statements" that are based on Managementís current expectations. Factors that could cause future results to differ materially from such expectations include, but are not limited to: the success of the Companyís research strategy; the applicability of discoveries made therein; the difficulties inherent in the development of pharmaceuticals, including uncertainties as to the timing and results of preclinical studies; delayed achievements of milestones; reliance on collaborators; uncertainty as to whether the Companyís potential products will succeed in entering human clinical trials and uncertainty as to the results of such trials; uncertainty as to whether adequate reimbursement for these products will exist from the government.
Views: 554
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: PharmaMar
 ‐ More of their Presentations
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Contents:
CORPORATE PRESENTATION
November 2016

CORPORATE PRESENTATION
March 2017

Disclaimer

This document includes only summary information and is not intended to be comprehensive. This
document includes "forward-looking statements" that are based on Management’s current expectations.
Factors that could cause future results to differ materially from such expectations include, but are not
limited t ... See more

Recent Presentations

Jeff Olsen MD
15 December, 2017
...
14 December, 2017
...
13 December, 2017